OTCMKTS:EXETF Extendicare (EXETF) Stock Price, News & Analysis → Shocking: One AI startup's revenue could surge 4,735% (From Manward Press) (Ad) Free EXETF Stock Alerts $5.47 0.00 (0.00%) (As of 05/10/2024 ET) Add Compare Share Share Today's Range$5.47▼$5.4750-Day Range$5.05▼$5.8352-Week Range$4.10▼$5.83Volume5 shsAverage Volume4,871 shsMarket CapitalizationN/AP/E RatioN/ADividend Yield8.78%Price TargetN/A Stock AnalysisStock AnalysisChartDividendHeadlinesShort InterestStock AnalysisChartDividendHeadlinesShort Interest Get Extendicare alerts: Email Address Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… About Extendicare Stock (OTCMKTS:EXETF)Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties. It operates through the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was incorporated in 1968 and is based in Markham, Canada.Read More EXETF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EXETF Stock News HeadlinesApril 15, 2024 | globenewswire.comExtendicare Announces April 2024 Dividend of C$0.04 per ShareMarch 27, 2024 | finance.yahoo.comOntario Nurses' Association Pickets at Extendicare Canada to Launch Nursing Homes Bargaining Campaign Calling for Care, Not ProfitMay 12, 2024 | Manward Press (Ad)Shocking: One AI startup's revenue could surge 4,735%Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.March 15, 2024 | msn.comKingston looks at primary health clinic option for former Extendicare facilityMarch 7, 2024 | globenewswire.comExtendicare Announces 2023 Fourth Quarter and Year End ResultsFebruary 29, 2024 | wsj.comExtendicare Inc.February 15, 2024 | prnewswire.comExtendicare Opens the MarketFebruary 15, 2024 | globenewswire.comExtendicare Announces February 2024 Dividend of C$0.04 per ShareMay 12, 2024 | Manward Press (Ad)Shocking: One AI startup's revenue could surge 4,735%Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.February 5, 2024 | msn.comNeighbours oppose plans for supportive housing at Kingston Extendicare facilityFebruary 2, 2024 | msn.comCity of Kingston buys Extendicare facility, supportive housing plannedJanuary 22, 2024 | msn.comExtendicare Kirkland Lake declares suspected enteric outbreakJanuary 10, 2024 | msn.comExtendicare Kirkland Lake declares COVID-19 outbreakNovember 13, 2023 | seekingalpha.comExtendicare Inc. (EXETF) Q3 2023 Earnings Call TranscriptNovember 10, 2023 | finanznachrichten.deExtendicare Inc: Extendicare Announces 2023 Third Quarter ResultsNovember 8, 2023 | finance.yahoo.comThose who invested in Extendicare (TSE:EXE) five years ago are up 19%October 6, 2023 | markets.businessinsider.comExtendicare Announces Timing of 2023 Third Quarter Results and Conference CallSeptember 13, 2023 | finance.yahoo.comShould You Investigate Extendicare Inc. (TSE:EXE) At CA$6.16?August 17, 2023 | markets.businessinsider.comRBC Capital Keeps Their Hold Rating on Extendicare (EXE)August 11, 2023 | msn.comWorkers at Extendicare Kingston on information picket line over payroll issuesAugust 11, 2023 | finanznachrichten.deExtendicare Inc: Extendicare Announces 2023 Second Quarter ResultsAugust 11, 2023 | markets.businessinsider.comExtendicare Announces 2023 Second Quarter ResultsJuly 16, 2023 | theglobeandmail.comExtendicare: Stocks Overvalued by Analyst Consensus on TSX (EXE)July 6, 2023 | benzinga.comExtendicare Announces Timing of 2023 Second Quarter Results and Conference CallJune 15, 2023 | finance.yahoo.comExtendicare Announces June 2023 Dividend of C$0.04 per ShareJune 12, 2023 | theglobeandmail.comClosing Bell: Extendicare Inc 5 Pct Debs down on Monday (EXE-DB-C)May 29, 2023 | finance.yahoo.comExtendicare Announces Voting Results for its 2023 Annual Meeting of ShareholdersSee More Headlines Receive EXETF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 4/15 Dividend3/27/2024Dividend Payable4/15/2024Ex-Dividend for 5/15 Dividend4/29/2024Today5/12/2024Dividend Payable5/15/2024Next Earnings (Estimated)5/15/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Care Facilities Sub-IndustryN/A Current SymbolOTCMKTS:EXETF CUSIPN/A CIKN/A Webwww.extendicare.com Phone(905) 470-4000FaxN/AEmployees23,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesDr. Michael R. Guerriere M.D. (Age 59)MBA, CEO, President & Director Comp: $887.72kMr. David E. BaconSenior VP & CFOMr. Steve ParaskevopoulosSenior Vice President of ParaMed & CTOMr. John ToffolettoSenior VP, Chief Legal Officer & Corporate SecretaryDr. Matthew MorganChief Medical OfficerJoe BelinskyVP of Information Technology & Chief Information OfficerMs. Jillian E. FountainVice President of Investor RelationsMs. Kathryn Killoran BradleyVice President of Corporate DevelopmentMs. Katie LeMoyneSenior VP & Chief Human Resources OfficerMs. Wendy GilmourSenior Vice President of Long-term Care OperationsMore ExecutivesKey CompetitorsAmerican Oncology NetworkNASDAQ:AONCWAmerican Oncology NetworkNASDAQ:AONCBangkok Dusit Medical Services PublicOTCMKTS:BDULFBumrungrad Hospital PublicOTCMKTS:BUHPFCareRxOTCMKTS:CHHHFView All Competitors EXETF Stock Analysis - Frequently Asked Questions How have EXETF shares performed in 2024? Extendicare's stock was trading at $5.4940 at the beginning of 2024. Since then, EXETF shares have decreased by 0.4% and is now trading at $5.47. View the best growth stocks for 2024 here. Are investors shorting Extendicare? Extendicare saw a decline in short interest in the month of April. As of April 15th, there was short interest totaling 469,100 shares, a decline of 20.8% from the March 31st total of 592,200 shares. Based on an average daily trading volume, of 1,800 shares, the short-interest ratio is currently 260.6 days. View Extendicare's Short Interest. When is Extendicare's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 15th 2024. View our EXETF earnings forecast. How often does Extendicare pay dividends? What is the dividend yield for Extendicare? Extendicare declared a dividend on Saturday, April 20th. Shareholders of record on Tuesday, April 30th will be paid a dividend of $0.0291 per share on Wednesday, May 15th. This represents a dividend yield of 6.61%. The ex-dividend date of this dividend is Monday, April 29th. Read our dividend analysis for EXETF. Is Extendicare a good dividend stock? Extendicare (OTCMKTS:EXETF) pays an annual dividend of $0.48 per share and currently has a dividend yield of 8.00%. EXETF has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for EXETF. How do I buy shares of Extendicare? Shares of EXETF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:EXETF) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward Press[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Extendicare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
